The story of the proteasome inhibitor bortezomib, or Velcade, ended happily, if not where anyone expected, when a collaborative effort to reverse muscle wasting led to the discovery of a lifesaving drug for multiple myeloma.
Found in Translation: The Tale of the Cancer Drug Bortezomib (Velcade)
